4
Changes in Ownership
Spero Therapeutics, Inc. Filed Acc 0000950170-24-011501
Chief Operating Officer sold 30,971 shares at $1.36 ($42,121)
- Chief Operating Officer acquired 239,731 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Keutzer Timothy Chief Operating Officer | 2024-02-01 | Grant or award | +239,731 | 565,021 | D | ||
| Keutzer Timothy Chief Operating Officer | 2024-02-02 | Sale | −30,971 | $1.36 | $42,121 | 534,050 | D |
| Open-market sales · 30,971 sh · avg $1.36 · $42,121 | |||||||
Loading xslF345X05/ownership.xml…